文献速递眼底病与葡萄膜炎

COVID-19大流行封锁对玻璃体内治疗结局的国际影响:Fight Retinal Blindness登记研究

INTERNATIONAL IMPACT OF THE COVID-19 PANDEMIC LOCKDOWN ON INTRAVITREAL THERAPY OUTCOMES: Fight Retinal Blindness Registry.
PubMed 文献 · Retina · 2022-01-01

这项多中心国际数据库研究纳入8个国家5,782只眼(4,708例患者),评估COVID-19封锁对新生血管性年龄相关性黄斑变性、糖尿病黄斑水肿和视网膜静脉阻塞玻璃体内抗VEGF治疗结局的影响。结果显示封锁后注射和访视次数减少,新生血管性年龄相关性黄斑变性眼在所有国家均出现视力下降,且下降程度与注射次数减少成比例;糖尿病黄斑水肿和视网膜静脉阻塞眼视力变化各异。结论提示优先保障新生血管性年龄相关性黄斑变性眼的治疗似乎是适当的。

要点

  • 新生血管性年龄相关性黄斑变性眼在封锁后所有国家均出现视力下降,且与注射次数减少成比例。
  • 封锁后6个月脱落率:新生血管性年龄相关性黄斑变性20%、糖尿病黄斑水肿27%、视网膜静脉阻塞28%。
  • 作者认为优先保障新生血管性年龄相关性黄斑变性眼的治疗似乎是适当的。

核心结论

  • 这项国际研究估算了COVID-19大流行封锁对玻璃体内治疗的影响,并提示优先保障新生血管性年龄相关性黄斑变性眼的治疗似乎是适当的。

研究设计与样本

  • 多中心国际数据库研究,纳入8个国家5,782只眼(4,708例患者),这些眼在 national lockdown 前、中、后接受玻璃体内抗血管内皮生长因子注射。
  • 基线访视定义为封锁前3个月内的最后一次访视,封锁前和封锁后期间分别定义为封锁日期前6个月和封锁日期后6个月。

主要发现

  • 新生血管性年龄相关性黄斑变性眼(n=4,649)在所有国家均出现视力下降,且下降程度与注射次数减少成比例;封锁后平均视力变化范围为-0.4至-3.8 logMAR字母,注射/访视次数中位数从4-5/4-7降至封锁后2-4/2-4。
  • 糖尿病黄斑水肿眼(n=654)封锁后平均视力变化范围为-2.8至+1.7字母,注射/访视次数中位数从2.5-5/4-6降至1-3/2-4。
  • 视网膜静脉阻塞眼(n=479)封锁后平均视力变化范围为-1.6至+0.1字母,注射/访视次数中位数从3-5.5/4-5降至1-3.5/2-3.5。
  • 封锁后6个月脱落率:新生血管性年龄相关性黄斑变性为20%,糖尿病黄斑水肿为27%,视网膜静脉阻塞为28%。

临床怎么用

  • 作者认为优先保障新生血管性年龄相关性黄斑变性眼的治疗似乎是适当的。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the impact of the COVID-19 pandemic lockdowns on the outcomes of eyes treated for neovascular age-related macular degeneration, diabetic macular edema, and retinal vein occlusion in eight countries. METHODS: A multicenter international database study of 5,782 eyes (4,708 patients) receiving intravitreal antivascular endothelial growth factor injections before, during, and after national lockdowns. The baseline visit was defined as the last visit within 3 months before lockdown, and prelockdown and postlockdown periods were defined as 6 months before and after the lockdown date. RESULTS: Eyes with neovascular age-related macular degeneration (n = 4,649) lost vision in all countries in proportion to the reduced number of injections. The mean visual acuity change postlockdown ranged from -0.4 to -3.8 logarithm of the minimum angle of resolution letters, and the median number of injections/visits decreased from 4-5/4-7 to 2-4/2-4 postlockdown. The diabetic macular edema (n = 654) and retinal vein occlusion (n = 479) eyes' mean visual acuity change ranged from -2.8 to +1.7 letters and -1.6 to +0.1 letters, and the median number of injections/visits decreased from 2.5-5/4-6 to 1-3/2-4 and from 3-5.5/4-5 to 1-3.5/2-3.5, respectively. The 6-month dropout rates postlockdown were 20% for neovascular age-related macular degeneration, 27% for diabetic macular edema, and 28% for retinal vein occlusion. CONCLUSION: This international study provides estimates of the impact of COVID-19 pandemic lockdown on intravitreal therapy and suggests that prioritizing neovascular age-related macular degeneration eyes seems appropriate.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Zarranz-Ventura J, Nguyen V, Creuzot-Garcher C, et al. INTERNATIONAL IMPACT OF THE COVID-19 PANDEMIC LOCKDOWN ON INTRAVITREAL THERAPY OUTCOMES: Fight Retinal Blindness Registry. Retina. 2022. PMID: 34907129. doi:10.1097/IAE.0000000000003368

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。